Latest Articles
New NCCN Guidlines on Colorectal, Endometrial, Esophageal, and Gastric Cancer Released - ICARE - Oncodaily
New NCCN Guidlines on Colorectal, Endometrial, Esophageal, and Gastric Cancer Released - ICARE Oncodaily
Published: June 20, 2026, 5:02 p.m.
Dostarlimab Provides Long-Term Benefits in dMMR/MSI-H Endometrial Cancer - OncLive
Dostarlimab Provides Long-Term Benefits in dMMR/MSI-H Endometrial Cancer OncLive
Published: June 20, 2026, 1:04 p.m.
How AI imaging technique detects early endometrial cancer with accuracy - Medical Buyer
How AI imaging technique detects early endometrial cancer with accuracy Medical Buyer
Published: June 20, 2026, 10:17 a.m.
The role of anti-Müllerian hormone as a therapeutic agent to preserve the ovarian follicle pool during chemotherapy.
Cancer treatments can deplete the ovarian follicle reserve, causing infertility and early menopause, with subsequent decline in cardiovascular, cognitive, and overall women's health. Medical measures to prevent this chemotherapy-induced ovarian …
Published: June 20, 2026, midnight
Nivolumab Produces 68% Clinical CR Rate in Resectable dMMR Endometrial Cancer - OncLive
Nivolumab Produces 68% Clinical CR Rate in Resectable dMMR Endometrial Cancer OncLive
Published: June 19, 2026, 5:49 p.m.
Puxitatug Samrotecan Hits 60% Response Rate in Platinum- and IO-Pretreated Endometrial Cancer - Targeted Oncology
Puxitatug Samrotecan Hits 60% Response Rate in Platinum- and IO-Pretreated Endometrial Cancer Targeted Oncology
Published: June 19, 2026, 5:05 p.m.
Quick optical biopsy could be early detection method for endometrial cancer - Medical Xpress
Quick optical biopsy could be early detection method for endometrial cancer Medical Xpress
Published: June 19, 2026, 3:40 p.m.
Fertility-Preserving Therapy May Impair Endometrial Function and IVF Success After Endometrial Cancer:... - Medical Dialogues
Fertility-Preserving Therapy May Impair Endometrial Function and IVF Success After Endometrial Cancer:... Medical Dialogues
Published: June 19, 2026, 2:30 p.m.
Palbociclib Plus Anastrozole Is Safe and Effective in ER+ Recurrent Endometrial Cancer - OncLive
Palbociclib Plus Anastrozole Is Safe and Effective in ER+ Recurrent Endometrial Cancer OncLive
Published: June 19, 2026, 1:08 p.m.
Exploring Women's Experiences of Information Across Their Endometrial Cancer Diagnosis and Treatment - Docwire News
Exploring Women's Experiences of Information Across Their Endometrial Cancer Diagnosis and Treatment Docwire News
Published: June 19, 2026, 10:17 a.m.
Link copied to clipboard!